News

Catch up on coverage from the second day of the 2025 Elevate-Derm Summer Conference held in Park City, Utah.

Ata Moshiri, MD, MPH, FAAD, spoke about pathology interpretation and patient communication at Elevate-Derm Summer 2025, enhancing skin cancer diagnosis.

Catch up on coverage from the second day of the 50th Annual Society for Pediatric Dermatology Meeting in Seattle, Washington.

DERM 2025 featured tips and tricks for a thorough pruritus diagnosis and treatment strategy from Adam Friedman, MD.

At Elevate-Derm Summer, Jim Treat, MD, outlined diagnostic limitations of imaging and the importance of recognizing capillary malformation patterns linked to other diseases.

Swanson discussed new and upcoming therapeutics, and how she approaches treatment options with caregivers.

Discover Walter Liszewski, MD's insights on emerging therapies and consumer safety at Elevate-Derm Summer 2025, focusing on allergy research and treatment advancements.

Schachner was the 2025 recipient of the AAP Alvin H. Jacobs award at the 50th annual SPD meeting.

Lisa Swanson, MD, discusses the unmet needs in pediatric dermatology at the DERM 2025 conference.

Hure details what clinicians need to know to protect their patients.

Discover how gene expression profiling transforms melanoma and SCC management, enhancing personalized treatment strategies and improving patient outcomes in skin cancer care.

The DERM 2025 midway recap includes tips for atopic dermatitis, chronic hand eczema, and pruritus.

Rheumatologist Karim Ladak, MD, shared diagnostic and treatment tips for cutaneous lupus at DERM 2025.

Catch up on coverage from the first day of the 2025 Elevate-Derm Summer Conference held in Park City, Utah.

Catch up on coverage from the first day of the 50th Annual Society for Pediatric Dermatology Meeting in Seattle, Washington.

Explore the INTEGUMENT-INFANT study, assessing roflumilast cream's safety and efficacy for infants with atopic dermatitis in a groundbreaking trial.

Walter Liszewski, MD, highlights the clinical impact of patch testing and shares strategies for selecting and dosing JAK inhibitors at Elevate-Derm Summer.

Discover innovative research pearls at the Elevate-Derm Summer Conference 2025, focusing on psoriasis, skin cancer, and more.

Discover insights from SPD 2025 on pediatric obesity treatment, emphasizing multidisciplinary care and innovative therapies.

New findings at Elevate Derm highlight remibrutinib's rapid and sustained efficacy in reducing chronic spontaneous urticaria symptoms, offering hope for patients.

Psoriasis in high impact areas responded well to icotrokinra, presenting a potential exciting option for patients.

At the DERM 2025 conference, Scott Boswell, MD, shares tips for combining therapies.

James Song, MD, discussed his UnlIMMited DERM 2025 poster detailing risankizumab's efficacy for genital and scalp psoriasis.

The approval makes delgocitinib cream the first and only approved therapy in the US for CHE in adults.

Join Dermatology Times at the 2025 Elevate-Derm Summer Conference for expert insights and live updates from Park City, Utah.

Joe Gorelick, MSN, FNP-C, discusses upcoming highlights and new data expected at the upcoming DERM 2025 CME Conference.

Jacob Thyssen, PhD, discusses tralokinumab's promising results for hand eczema, highlighting its potential to transform treatment options for patients.

Castle Biosciences’ DecisionDx-Melanoma test plays a role in melanoma management with precise risk stratification, enhancing patient outcomes and reducing unnecessary surgeries.

Tildrakizumab, HCP-administered biologics, and lifestyle-based decision-making took center stage in an interactive discussion led by Omar Noor, MD, FAAD, and colleagues.